Neuropeptide W-23 (human)
Cat. No. 3009
Alternative Name: NPW-23
Biological ActivityEndogenous peptide agonist of Neuropeptide B/Neuropeptide W receptors NPBW1 and NPBW2 (previously known as GPR7 and GPR8 respectively). Increases food intake following injection into the paraventricular nucleus.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
Hondo et al (2008) The NPB/NPW neuropeptide system and its role in regulating energy homeostasis, pain, and emotion. Results Probl.Cell Differ. 46 239. PMID: 18204824.
Levine et al (2005) Injection of neuropeptide W into paraventricular nucleus of hypothalamus increases food intake. Am.J.Physiol.Regul.Integr.Comp.Physiol. 288 R1727. PMID: 15886360.
Brezillon et al (2003) Identification of natural ligands for the orphan G prortein-coupled receptors GPR7 and GPR8. J.Biol.Chem. 278 776. PMID: 12401809.
Shimomura et al (2002) Identification of neuropeptide W as the endogenous ligand for orphan G-protein-coupled receptors GPR7 and GPR8. J.Biol.Chem. 277 35826. PMID: 12130646.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Neuropeptide W-23 (human) from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Neuropeptide W-23 (human), supplier, Endogenous, NPBW1, NPBW2, agonists, Receptors, Neuropeptides, B, W, NPW23, GPR7, GPR8, Tocris Bioscience, Other Peptide Receptor products
Find multiple products by catalog number
New Products in this Area
Non-peptide apelin receptor agonistBML 111
FPR2 (lipoxin A4 receptor) agonistAmylin (rat)
Potent endogenous peptide agonist for amylin, calcitonin, CGRP and adrenomedullin receptorsCalcitonin (human)
Endogenous calcitonin receptor agonist; inhibits bone resorptionSpexin
Potent GAL2/3 agonist; exhibits anxiolytic effects in vivoMM 54
Potent apelin receptor antagonist
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.